{"url_path":"/sec/clir/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 **UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1434524/0001104659-26-061940-index.html","accession_number":"0001104659-26-061940","cik":"0001434524","ticker":"CLIR","issuer_name":"ClearSign Technologies Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1434524/0001104659-26-061940-index.html","primary_entity_key":"0001434524","primary_entity_name":"ClearSign Technologies Corp"},"word_count":131,"has_tables":true,"body_markdown":"**ITEM 2.**UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS\n\n​\n\nOn November 11, 2025, the Board authorized issuance of 1,500 shares to be remitted in quarterly installments to our investor relations firm, Firm IR Group LLC (“Firm IR”), for services rendered by them, pursuant to our 2013 Consultant Stock Plan. On March 30, 2026, we issued 375 shares of common stock to Firm IR at a fair market value price per share of $8.59, the closing price of our common stock as reported on Nasdaq on November 11, 2025, the date of grant, as adjusted for the Reverse Split. These shares were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act, for a transaction by an issuer not involving a public offering.\n\n​"}